IQ / USDT

BIGTIME / USDT

ARK / USDT

BIGTIME / USDC

ARK / TRY

BIO / USDT

BIO / USDC

BIO / TRY

BIO / FDUSD

ACA / BTC

STRAX / USDT

ARDR / BTC

BEL / TRY

BEL / BTC

BEL / USDT

ARDR / USDT

GAS / BTC

GAS / TRY

GAS / USDT

BABY / BNB

FUSION FINANCE LIMITED

SECMARK CONSULTANCY LTD

GOLDSTAR POWER LIMITED

OSWAL GREENTECH LIMITED

SMS LIFESCIENCES (I) LTD

OSWAL AGRO MILLS LTD

FACT LTD

DEEM ROLL TECH LIMITED

ASHIMA LTD

AGARWAL TOUGH GLASS IND L

AKME FINTRADE (INDIA) LTD

BODHI TREE MULTIMEDIA LTD

VIKAS LIFECARE LIMITED

CROP LIFE SCIENCE LIMITED

RAJ OIL MILLS LIMITED

TWAMEV CONS AND INFRA LTD

SAROJA PHARMA INDUS IND L

ARISTO BIO T AND LIFESC L

ACCENT MICROCELL LIMITED

DYNEMIC PRODUCTS LIMITED

Click here to get full coverage on ‘Estimados Señores’ Honors The Women Who Changed Colombia - The Loyola Phoenix

‘Estimados Señores’ Honors The Women Who Changed Colombia  The Loyola Phoenix

‘Estimados Señores’ Honors The Women Who Changed Colombia - The Loyola Phoenix

Click here to get full coverage on Senores Pharmaceuticals Stock Price: Latest Updates and Market Trends - LKO Uniexam.in

Senores Pharmaceuticals Stock Price: Latest Updates and Market Trends  LKO Uniexam.in

Senores Pharmaceuticals Stock Price: Latest Updates and Market Trends - LKO Uniexam.in

Click here to get full coverage on Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market - Business Wire

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market  Business Wire

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market - Business Wire

Click here to get full coverage on Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories - The Economic Times

Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories  The Economic Times

Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories - The Economic Times

Click here to get full coverage on Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility - TipRanks

Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility  TipRanks

Senores Pharmaceuticals Issues Corporate Guarantee for Subsidiary’s Credit Facility - TipRanks

Click here to get full coverage on Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue - MarketScreener

Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue  MarketScreener

Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue - MarketScreener

Click here to get full coverage on Carraro India, Ventive, Senores Pharma — Stocks Down As Second Anchor Lock-In Ends - NDTV Profit

Carraro India, Ventive, Senores Pharma — Stocks Down As Second Anchor Lock-In Ends  NDTV Profit

Carraro India, Ventive, Senores Pharma — Stocks Down As Second Anchor Lock-In Ends - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Downturn - MarketsMojo

Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Downturn  MarketsMojo

Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Downturn - MarketsMojo

Click here to get full coverage on Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion - CNBC TV18

Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion  CNBC TV18

Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion - CNBC TV18

Click here to get full coverage on Senores Pharmaceuticals Acquires 14 ANDAs From Dr. Reddy’s To Strengthen US Portfolio - BW Healthcare World

Senores Pharmaceuticals Acquires 14 ANDAs From Dr. Reddy’s To Strengthen US Portfolio  BW Healthcare World

Senores Pharmaceuticals Acquires 14 ANDAs From Dr. Reddy’s To Strengthen US Portfolio - BW Healthcare World

Click here to get full coverage on US uncertainty: Senores Pharma treads, where other drugmakers wait with caution - BusinessLine

US uncertainty: Senores Pharma treads, where other drugmakers wait with caution  BusinessLine

US uncertainty: Senores Pharma treads, where other drugmakers wait with caution - BusinessLine

Click here to get full coverage on Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals - Indian Pharma Post

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals  Indian Pharma Post

Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals - Indian Pharma Post

Click here to get full coverage on Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets - Business Standard

Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets  Business Standard

Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets - Business Standard

Click here to get full coverage on Chicos de campo, señores. - Instagram

Chicos de campo, señores. - Instagram

Click here to get full coverage on Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details | Stock Market News - Mint

Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details | Stock Market News  Mint

Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details | Stock Market News - Mint

Click here to get full coverage on Senores Pharmaceuticals Bets Big On US Expansion And Robust Pipeline - NDTV Profit

Senores Pharmaceuticals Bets Big On US Expansion And Robust Pipeline  NDTV Profit

Senores Pharmaceuticals Bets Big On US Expansion And Robust Pipeline - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals Increases Stake in Havix Group - TipRanks

Senores Pharmaceuticals Increases Stake in Havix Group  TipRanks

Senores Pharmaceuticals Increases Stake in Havix Group - TipRanks

Click here to get full coverage on Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees - Mint

Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees  Mint

Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees - Mint

Click here to get full coverage on Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets - Indian Pharma Post

Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets  Indian Pharma Post

Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Challenges - MarketsMojo

Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Challenges  MarketsMojo

Senores Pharmaceuticals Faces Significant Stock Decline Amid Broader Market Challenges - MarketsMojo

Click here to get full coverage on Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ... - The Economic Times

Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ...  The Economic Times

Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ... - The Economic Times

Click here to get full coverage on Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories - Indian Pharma Post

Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories  Indian Pharma Post

Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals IPO: Price Band, Financials, Key Risks, GMP And More — All You Need To Know - NDTV Profit

Senores Pharmaceuticals IPO: Price Band, Financials, Key Risks, GMP And More — All You Need To Know  NDTV Profit

Senores Pharmaceuticals IPO: Price Band, Financials, Key Risks, GMP And More — All You Need To Know - NDTV Profit

Click here to get full coverage on Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band - The Economic Times

Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band  The Economic Times

Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price band - The Economic Times

Click here to get full coverage on Senores Pharma has niche positives, can be a long-term bet - The Economic Times

Senores Pharma has niche positives, can be a long-term bet  The Economic Times

Senores Pharma has niche positives, can be a long-term bet - The Economic Times

Click here to get full coverage on Senores Pharmaceuticals gets SEBI nod for IPO - Indian Pharma Post

Senores Pharmaceuticals gets SEBI nod for IPO  Indian Pharma Post

Senores Pharmaceuticals gets SEBI nod for IPO - Indian Pharma Post

Click here to get full coverage on IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up... - Moneycontrol

IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up...  Moneycontrol

IPO lock-in expiry: Senores Pharmaceutical, Ventive Hospitality, Carraro India crack 8% as shares freed up... - Moneycontrol

Click here to get full coverage on Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix - Business Standard

Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix  Business Standard

Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix - Business Standard

Click here to get full coverage on IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals? - Mint

IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals?  Mint

IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals? - Mint

Click here to get full coverage on Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close - Moneycontrol

Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close  Moneycontrol

Senores Pharmaceuticals IPO listing bonanza: shares debut at 53% premium, pare gains at close - Moneycontrol

Click here to get full coverage on D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5 - LinkedIn

D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5  LinkedIn

D-Street Debut: Senores Pharma Senores Pharmaceuticals Limited made a healthy stock market debut, with shares getting listed at ₹600, a 53.45% premium to its issue price of ₹391/share on the NSE. On the BSE, the stock made debut at ₹593.70/share, a 5 - LinkedIn

Click here to get full coverage on Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price | Stock Market News - Mint

Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price | Stock Market News  Mint

Senores Pharmaceuticals Share Price Highlights: Stock ends 6% below listing price but 43% above IPO price | Stock Market News - Mint

Click here to get full coverage on Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25 - Indian Pharma Post

Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25  Indian Pharma Post

Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25 - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals IPO lists at 53% premium - Indian Pharma Post

Senores Pharmaceuticals IPO lists at 53% premium  Indian Pharma Post

Senores Pharmaceuticals IPO lists at 53% premium - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals IPO listing: Does GMP suggest strong market debut? - India Today

Senores Pharmaceuticals IPO listing: Does GMP suggest strong market debut?  India Today

Senores Pharmaceuticals IPO listing: Does GMP suggest strong market debut? - India Today

Click here to get full coverage on Senores Pharma buys USFDA approved ANDA for COPD drug - Medical Dialogues

Senores Pharma buys USFDA approved ANDA for COPD drug  Medical Dialogues

Senores Pharma buys USFDA approved ANDA for COPD drug - Medical Dialogues

Click here to get full coverage on Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch - NDTV Profit

Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch  NDTV Profit

Senores Pharmaceuticals IPO GMP Hints At Strong Listing Gain Before Launch - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals Shares Close 6% Lower On Listing Day - NDTV Profit

Senores Pharmaceuticals Shares Close 6% Lower On Listing Day  NDTV Profit

Senores Pharmaceuticals Shares Close 6% Lower On Listing Day - NDTV Profit

Click here to get full coverage on Senores Pharmaceuticals begins operations at greenfield API facility - Indian Pharma Post

Senores Pharmaceuticals begins operations at greenfield API facility  Indian Pharma Post

Senores Pharmaceuticals begins operations at greenfield API facility - Indian Pharma Post

Click here to get full coverage on Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s - Moneycontrol

Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s  Moneycontrol

Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s - Moneycontrol

Click here to get full coverage on IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week - NDTV Profit

IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week  NDTV Profit

IPO GMP Of Unimech Aerospace And Senores Pharmaceuticals Soars Ahead Of Listing Next Week - NDTV Profit

Click here to get full coverage on Senores Pharma outlines inorganic strategy to expand product pipeline - VCCircle

Senores Pharma outlines inorganic strategy to expand product pipeline  VCCircle

Senores Pharma outlines inorganic strategy to expand product pipeline - VCCircle

Click here to get full coverage on Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not? - Mint

Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not?  Mint

Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not? - Mint

Click here to get full coverage on Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue - Mint

Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue  Mint

Senores Pharmaceuticals IPO raises ₹261 crore from anchor investors ahead of public issue - Mint

Click here to get full coverage on Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold? - Mint

Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold?  Mint

Senores Pharmaceuticals share price dips over 6% after strong debut in Indian stock market. Buy, sell or hold? - Mint

Click here to get full coverage on Why Senores Pharma Share Price is Rising - Equitymaster

Why Senores Pharma Share Price is Rising  Equitymaster

Why Senores Pharma Share Price is Rising - Equitymaster

Click here to get full coverage on Senores Pharma IPO Over-Subscribed 93.69 Times - Rediff MoneyWiz

Senores Pharma IPO Over-Subscribed 93.69 Times  Rediff MoneyWiz

Senores Pharma IPO Over-Subscribed 93.69 Times - Rediff MoneyWiz

Click here to get full coverage on Senores Pharma Q3 Results: Shares zoom 17% as profit more than doubles; income up 35% - CNBC TV18

Senores Pharma Q3 Results: Shares zoom 17% as profit more than doubles; income up 35%  CNBC TV18

Senores Pharma Q3 Results: Shares zoom 17% as profit more than doubles; income up 35% - CNBC TV18

Click here to get full coverage on Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not? - Mint

Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not?  Mint

Senores Pharmaceuticals IPO day 3: GMP, subscription status to review. Apply or not? - Mint

Click here to get full coverage on Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key details - The Economic Times

Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key details  The Economic Times

Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key details - The Economic Times

Click here to get full coverage on Senores Pharma gains after arm inks pact to acquire Roflumilast tablets - Business Standard

Senores Pharma gains after arm inks pact to acquire Roflumilast tablets  Business Standard

Senores Pharma gains after arm inks pact to acquire Roflumilast tablets - Business Standard

Click here to get full coverage on Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online - Mint

Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online  Mint

Senores Pharmaceuticals IPO allotment status out. Latest GMP, how to check status online - Mint

Click here to get full coverage on Senores Pharmaceuticals Shares rises 6.91, acquires US rights for COPD drug - BusinessLine

Senores Pharmaceuticals Shares rises 6.91, acquires US rights for COPD drug  BusinessLine

Senores Pharmaceuticals Shares rises 6.91, acquires US rights for COPD drug - BusinessLine

Click here to get full coverage on Dr. Reddy's Launches Ivermectin Generic in $20M US Market Opportunity - Stock Titan

Dr. Reddy's Launches Ivermectin Generic in $20M US Market Opportunity  Stock Titan

SENORES PHARMACEUTICALS L (SENORES)

Price Chart

Key Statistics

Technicals

About SENORES

Latest News

‘Estimados Señores’ Honors The Women Who Changed Colombia - The Loyola Phoenix

Senores Pharmaceuticals Stock Price: Latest Updates and Market Trends - LKO Uniexam.in

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market - Business Wire

Advanced Charts

Top Gainers

Top Losers